Gilbert Kaufmann
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
01.01.2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
01.01.2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
Wolbers M, Bucher H, Kaufmann G, Bernasconi E, Vernazza P, Hasse B, Cavassini M, Furrer H, Hirschel B, Battegay M, Swiss HIV Cohort Study. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral therapy 2007; 12:889-97.
01.01.2007CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
01.01.2007Antiviral therapy 2007; 12:889-97
Wolbers Marcel, Bucher Heiner C, Kaufmann Gilbert, Bernasconi Enos, Vernazza Pietro, Hasse Barbara, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Swiss HIV Cohort Study